Article

January 29, 2015

90% of Consumers Stayed in Covered California

Of the 944,000 people who could renew their coverage for 2015 through Covered California, the state's health insurance exchange, 94% stayed in the same plan that they were in last year.

When it comes to health insurance, Californians seem to value consistency.

Of the 944,000 people who could renew their coverage for 2015 through Covered California, the state’s health insurance exchange, 94% stayed in the same plan that they were in last year.

About a third of them shopped for other plans available on the exchange, but few ended up making a change. The other two-thirds took no action and were automatically re-enrolled in their plan from last year.

Read more: http://bit.ly/1A2wvBW

Source: Kaiser Health News

Related Videos

Dr Raymond Osarogiagbon

Richard J. Nowak, MD, MS, Yale School of Medicine

Naim Alkhouri, MD

Jaime Almandoz, MD, MBA

Martin Edelman, MD

Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)

Pierluigi Porcu, MD

Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com

JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)

Related Content

COA signage | Image Credit: © Maggie L. Shaw

April 29th 2025

Advancing the Art of Medicine Through Partnership

Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discuss the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Alopecia areata. | Image Credit: cattyphoto - stock.adobe.com

April 29th 2025

Study Highlights Unmet Needs in Measuring Patient Experiences in Alopecia Areata

Cameron Santoro

Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported outcome measures (PROMs) specific to alopecia areata (AA), a common hair loss condition with substantial quality of life impacts.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

cigarettegraphic | Image Credit: © freshidea-stock.adobe.com

April 28th 2025

Health Gains From US Smoking Decline Fall Short of Expectations

Smoking prevalence is projected to decline by 2035, yet health consequences persist due to slower reductions among older adults.

Tailored approaches help patients with MM find the regimen that works best for them, which improves quality of life and outcomes | image credit: Dzmitry - stock.adobe.com

April 25th 2025

Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD

Kyle Munz Ajai Chari, MD

When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.

Related Content

COA signage | Image Credit: © Maggie L. Shaw

April 29th 2025

Advancing the Art of Medicine Through Partnership

Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discuss the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Alopecia areata. | Image Credit: cattyphoto - stock.adobe.com

April 29th 2025

Study Highlights Unmet Needs in Measuring Patient Experiences in Alopecia Areata

Cameron Santoro

Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported outcome measures (PROMs) specific to alopecia areata (AA), a common hair loss condition with substantial quality of life impacts.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

cigarettegraphic | Image Credit: © freshidea-stock.adobe.com

April 28th 2025

Health Gains From US Smoking Decline Fall Short of Expectations

Smoking prevalence is projected to decline by 2035, yet health consequences persist due to slower reductions among older adults.

Tailored approaches help patients with MM find the regimen that works best for them, which improves quality of life and outcomes | image credit: Dzmitry - stock.adobe.com

April 25th 2025

Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD

Kyle Munz Ajai Chari, MD

When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions